Palmitoylethanolamide is an endogenous cannabinoid. It is a weak ligand of the cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptors. It has been found to inhibit FAAH (fatty acid amide hydrolase). Palmitoylethanolamide exhibits anti-nociceptive, anti-inflammatory, anti-convulsant and immunosuppresant activity. Palmitoylethanolamide acts by binding to an unidentified cannabinoid receptor that is similar to CB2. It also acts as a selective activator of the GPR55 receptor. In addition, this compound directly activates PPARα, producing an anti-inflammatory response.An endogenous cannabinoid agonist, FAAH inhibitor, and PPARα agonist. Specification: ≥98% MDL Number: MFCD00020562 Molecular Formula: C18H37NO2 Molecular Weight: 299.492 PubChem CID: 4671 Isomeric SMILES: CCCCCCCCCCCCCCCC(=O)NCCO Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/N135851-SCI_a6174bbd2f4eb4e9b805bb7a6cca1ca9.pdf
- UPC:
- 12352211
- Condition:
- New
- Availability:
- 2 weeks
- Weight:
- 11.16 Ounces
- HazmatClass:
- Yes
- WeightUOM:
- LB
- MPN:
- N135851-100g
- CAS:
- 544-31-0
- Health Hazards:
- Corrosive
- Product Size:
- 100g
- Hazard Statement Codes:
- H315:H318:H411
- Precautionary Statement Codes:
- P264:P273:P280:P391:P302+P352:P305+P351+P338:P362+P364:P501
